Drug intelligence / Profile preview

THC KISS

Development stage
Unknown
Lead developer
THC BioMed
Modality
Small Molecules
Administration
Oral
01

Overview

THC KISS is a brand of cannabis-infused products developed and manufactured by THC BioMed, a licensed producer under Canada's Cannabis Act. The product line is most notable for its flagship 'Beverage Shot,' as well as biscuits and gummies, all formulated to contain a standardized dose of 10mg of Delta-9-tetrahydrocannabinol (THC) per unit. THC, the primary psychoactive constituent of cannabis, functions as a partial agonist at the G protein-coupled Cannabinoid receptor 1 (CB1) and Cannabinoid receptor 2 (CB2). Binding to CB1 receptors in the central nervous system inhibits the release of various neurotransmitters, including glutamate and GABA, which mediates the drug's analgesic, antiemetic, and psychotropic effects. THC KISS products are marketed in the Canadian legal cannabis market for both recreational use and the management of medical symptoms such as chronic pain and nausea.

Brand names
THC KISSTHC KISS Beverage ShotTHC KISS BiscuitsTHC KISS Gummies
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on THC KISS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on THC KISS.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call